NUDT1 and cancer: However, later independent studies failed to reproduce these results (arguing that the prior observations could be due to the off-target effects of NUDT1 siRNAs and/or small chemical inhibitors), challenging the notion of NUDT1 as a feasible, universal target for cancer therapy30–32.